Navigation Links
Heart patients are often not treated in accordance with guidelines
Date:11/21/2008

Many patients with cardiovascular disease are not given adequate drug therapy. This is the result of an international study. In the current edition of Deutsches rzteblatt International (Dtsch Arztebl Int 2008; 105[45]: 769-75), Uwe Zeimer et al. present the German results of this prospective, one-year survey.

512 doctors in Germany took part in the study. They enrolled 5594 patients in all, of whom 89.2% suffered from one or more cardiovascular diseases and 10.8% only exhibited risk factors. Documented risk factors included high blood pressure, disturbances in lipid metabolism, diabetes, and obesity. The results showed that several vascular beds were affected simultaneously in almost one third of patients. Many patients also suffered from other diseases requiring treatment, which were defined as risk factors. After one year, 2.1% of the patients with cardiovascular disease and 1.5% of the patients with at least three risk factors had died.

The study demonstrated that only three quarters of patients were given drugs to reduce fat levels. The same proportion was given drugs to dilute blood. Moreover, the doctors failed to exhaust the possibilities for drug treatment. This may be the reason that 27% of the patients with high blood pressure failed to reach the target blood pressure and 66% of the patients with disturbances in lipid metabolism failed to reach the target cholesterol level.


'/>"/>

Contact: Elke Bartholomaeus
bartholomaeus@aerzteblatt.de
49-223-470-11133
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Drug for cluster headaches may cause heart problems
2. Use of certain lipid measures not more effective in predicting coronary heart disease
3. Restricting Blood Flow May Help Heart Bypass Patients
4. Urban Smog Tough on Young Adults Hearts
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. Vitamin Es lack of heart benefit linked to dosage
7. Drug That Lowers Resting Heart Rate Being Tested
8. Heart Attack Boosts Diabetes Risk
9. Embryonic Stem Cells Repair Human Heart
10. U of M study: Early treatment can reverse heart damage
11. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... ... , ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon ... America, declared on her radio program in November 2016 the need to educate people ... attack leaders in corporate America, they are trying to take advantage of successful algorithms ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Facial plastic ... this holiday season by donating a portion of proceeds to two local organizations: North ... Chicago Animal Control & Friends is a team of authorized and trained volunteers ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas ... "scam operations" carried out by unethical locksmith companies and is urging Search Engines ... halt. According to Texas Premier Locksmith, these fraudulent locksmith services take advantage of ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... Dec. 6, 2016   Sienna Biopharmaceuticals, ... dermatology and aesthetics company, today announced it ... specialty pharmaceutical company focused on developing first-in-class ... including psoriasis, atopic dermatitis and pruritus (itch). ... will make an undisclosed upfront payment in ...
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
Breaking Medicine Technology: